JNJ
170.73
-0.23%↓
NVS
117.78
-0.02%↓
ABT
130.77
+0.52%↑
TMO
466.56
-0.22%↓
ISRG
476.87
-1.3%↓
JNJ
170.73
-0.23%↓
NVS
117.78
-0.02%↓
ABT
130.77
+0.52%↑
TMO
466.56
-0.22%↓
ISRG
476.87
-1.3%↓
JNJ
170.73
-0.23%↓
NVS
117.78
-0.02%↓
ABT
130.77
+0.52%↑
TMO
466.56
-0.22%↓
ISRG
476.87
-1.3%↓
JNJ
170.73
-0.23%↓
NVS
117.78
-0.02%↓
ABT
130.77
+0.52%↑
TMO
466.56
-0.22%↓
ISRG
476.87
-1.3%↓
JNJ
170.73
-0.23%↓
NVS
117.78
-0.02%↓
ABT
130.77
+0.52%↑
TMO
466.56
-0.22%↓
ISRG
476.87
-1.3%↓
24h
Actual
Mínimo
1.8
Máximo
1.89
Recomendaciones | Comprar |
---|---|
Estimación a 12 meses | +452.49% upside |
Próximas Ganancias | 11 ago 2025 |
---|
El rendimiento pasado no es un indicador fiable de resultados futuros.
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 10 USD 452.49%
Máximo 16 USD
Mínimo 4 USD
De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
2 ratings
2
Comprar
0
Mantener
0
Vender
De acuerdo con 2 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$